Common TitleA1444-040 (Sofosbuvir plus Daclatasvir)
Official Title Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection.
Phase Phase II
ClinicalTrials.gov NCT01359644
Treatments
Sofosbuvir
Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedFunding
IndustryBristol-Myers Squibb